| Literature DB >> 33096625 |
Zhiwei Liu1,2, Xian Sun2,3,4.
Abstract
Oxidative stress induces various cardiovascular, neurodegenerative, and cancer diseases, caused by excess reactive oxygen species (ROS). It is attributed to the lack of sufficient antioxidant defense capacity to eliminate unnecessary ROS. Seaweeds are largely cultivated for their edible and commercial purposes. Excessive proliferation of some seaweeds has occurred in coastal areas, causing environmental and economic disasters, and even threating human health. Removing and disposing of the excess seaweeds are costly and labor-intensive with few rewards. Therefore, improving the value of seaweeds utilizes this resource, but also deals with the accumulated biomass in the environment. Seaweed has been demonstrated to be a great source of polysaccharides antioxidants, which are effective in enhancing the antioxidant system in humans and animals. They have been reported to be a healthful method to prevent and/or reduce oxidative damage. Current studies indicate that they have a good potential for treating various diseases. Polysaccharides, the main components in seaweeds, are commonly used as industrial feedstock. They are readily extracted by aqueous and acetone solutions. This study attempts to review the current researches related to seaweed polysaccharides as an antioxidant. We discuss the main categories, their antioxidant abilities, their determinants, and their possible molecular mechanisms of action. This review proposes possible high-value ways to utilize seaweed resources.Entities:
Keywords: antioxidant; nuclear factor erythroid 2-related factor 2 (Nrf2); polysaccharide; seaweed
Mesh:
Substances:
Year: 2020 PMID: 33096625 PMCID: PMC7589308 DOI: 10.3390/ijms21207774
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Summary of recently reported antioxidant ability of seaweed polysaccharides.
| Type | Main Backbone | Source | Antioxidant Ability | Reference |
|---|---|---|---|---|
| Fucoidan | α-1,3-L-fucop | At 2.0 mg/mL: DPPH (μg/mL TE): 7.43 ± 0.99; OH (%): 75.97 ± 1.69 | [ | |
| At 2.0 mg/mL: DPPH (μg/mL TE): 8.05 ± 1.49; ·OH (%): 75.32 ± 1.08 | ||||
| At 2.0 mg/mL: TPC (mg GAE/100 g), 3.69 ± 0.15; DPPH (IC50 (mg/ml), 2.01 ± 0.29; O2− (%), 26.78 ± 1.90; ·OH (%), 60.95 ± 0.69; FRAP (mg GAE/100 g), 0.60 ± 0.08 | [ | |||
| Alginates | β-1,4-D-mannuronic acid (M) and α-1,4-L-guluronic acid (G) | At 0.5 mg/L: DPPH (%), 74%; At 4 and 5 mg/ml, ·OH: 80 and 82% | [ | |
| MW of 1–6 KDa and 6–10 KDa: O2− (I50): 8 μg mL−1 and 18 μg mL−1; OH (I50): 0.01 mg mL−1 and 0.03 mg mL−1 | [ | |||
| Laminarin | β-1,3- | DPPH: reach 93.23%/87.57%; TPC (mg PGE/g): 0.343–0.365/0.110–0.166 | [ | |
| Carrageenan | At 1 mg/mL, 0.25–0.50 wt% substrate and 1.0–5.0 wt% enzyme: FRAP (mM AAE/g), 58.50–98.22; O2− (%), 45.95–54.82% | [ | ||
| Agar | repeating D-galactose and 3,6-anhydro-L-galactose | SigmaeAldrich, USA | At 10 mg/ml, DPPH (%), 16.47–22.71%; ABTS (%), 61.95–81.26%; FRAP, 0.95–1.46 | [ |
| Ulvan | repeating disaccharide units, α-and β-(1,4)-linked monosaccharides | Among 0.025-0.800 mg/L: ABTS (%), 20.15–30.25; DPPH (%), 5.61–46.51; | [ |
AAE: ascorbic acid equivalents; ABTS: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid radical scavenging activity; DPPH: 2,2-diphenyl-1-picrylhydrazyl radical scavenging activity; FRAP: Ferric reducing antioxidant power; GAE: gallic acid; MW: molecular weight; TE: trolox equivalent; TPC: total phenolic content; PGE: phloroglucinol equivalents; OH: hydroxyl radicals scavenging activity; O2−: Superoxide anion radicals scavenging activity.
Summary of recently reported antioxidant ability from seaweed polysaccharides in animals.
| Seaweed | Compound | Source | Administration | Dose (mg/kg) | Markers | Tissues | Model | Reference |
|---|---|---|---|---|---|---|---|---|
| Red | Carrageenan | 2 days after induction, daily treatment, lasts 45 d | 500, 750 and 1000 | ↑CAT, GPx, SOD, GST, and GSH; ↓LPO | Liver | Alloxan induced diabetic rats | [ | |
| Sulfated polysaccharide | Before 18 h induction; pretreatment lasts 30 min | 3 and 10 | ↑CAT and SOD | ABAP induced Female Wistar rats | [ | |||
| Oligosaccharide |
| Pretreatment 2 h before induction, once daily, lasts 21 d; pretreatment daily, lasts 2 weeks, followed by induction daily for 3 weeks; pretreatment immediately followed by induction, once daily, lasts 2 weeks; induction daily, lasts 3 weeks, followed by treatment daily for 2 weeks | 50,150 and 250 | ↑GSH and SOD; | Alcohol induced male Kunming mice | [ | ||
| Brown | Sulfated polysaccharide | Pretreatment twice daily, lasts 5 days | 5670 | ↑SOD; ↓MDA | Kidney | Contrast-induced nephropathy rats | [ | |
| Pretreatment 2 h before induction, 3 times a week, lasts 9 weeks | 200, 400, 600 | ↑SOD and CAT; | Skin | UVB radiation induced hairless Kun Ming mice | [ | |||
| Fucoidan | Cool Chemistry CO. Ltd., China | Pretreatment once daily, lasts 7 days | 100 or 200 | ↑SOD, GSH and CAT | Liver | Acetaminophen induced male ICR mice | [ | |
| After induction, treatment once daily, lasts 14 days | 50, 100, 200 | ↑SDO and GPX; | Hippocampus | Aβ-induced Sprague–Dawley rats | [ | |||
| Sigma-Aldrich, USA | Pretreatment 2 h before induction, lasts 2 days | 100 | ↑GSH, GPx and SOD; | liver | Acetaminophen induced Sprague–Dawleyrats | [ | ||
| Twice daily, lasts 12 weeks | 110, 220 and 440/30, 60, 120 | ↑CAT and SOD; | blood | yellow catfish ( | [ | |||
| Alginic acid oligosaccharide | Dalian Institute of Chemical Physics, | Daily, lasts 21 days | 100 | ↑SOD, CAT, T-AOC and GPx; | weaned pigs | [ | ||
| Green | Sulfated polysaccharide | After induction, treatment daily, lasts 4 weeks; pretreatment 4 weeks before induction | 100 | ↑CAT and SOD | liver | D-galactosamine induced Adult male Albino Wistar rats | [ |
ABAP: 2,2′-azobis (2-methylpropionamidine) dihydrochloride; Aβ: amyloid beta peptide; CAT: Catalase; GPx: glutathione peroxidase; GSH: glutathione; GST: glutathione S-transferase; ICR: Institute of Cancer Research; LPO: Lipid peroxidation; MDA: malondialdehyde; SOD: superoxide dismutase; TAOC: total antioxidant capacity; UVB: ultraviolet B; The arrows upward represent increase and the downward represent decrease.
Summary of recently reported antioxidant ability from seaweed polysaccharides in cell lines.
| Seaweed | Compound | Source | Administration | Dose (mg/mL) | Markers | Model | Reference |
|---|---|---|---|---|---|---|---|
| Brown | Alginate | Sigma Aldrich, USA | Pretreatment 1 h before induction; | 0.030 | ↑GSH | H2O2-induced NT2 neurons | [ |
| Fucoidan | Cool Chemistry CO., China | Pretreatment 4 h before induction | 0.025. 0.050 and 0.100 | ↑GSH and SOD; ↓ROS and MDA | Acetaminophen induced | [ | |
| Co-treatment with induction, lasts 6 h | 0.050-0.500 | ↑SOD; ↓ROS, | H2O2 induced pre- osteoblast-like | [ | |||
| Laminarin | Sigma-Aldrich, USA | Treatment 1 h before or after induction | 0.020 | ↑SOD, GSH and CAT; ↓MDA | H2O2 induced Human lung fibroblasts MRC-5 cells | [ | |
| Sulfated polysaccharide | Pretreatment 24 h before induction | 0.500 | ↑GSH | Ethanol induced rat intestinal cell line IEC-6 | [ | ||
| Green | Ulvan | Pretreatment 2 h before induction | 0.100 and 0.200 | ↑SOD and CAT | H2O2 induced RAW264.7 murine macrophage cell line | [ | |
| Sulfated Polysaccharides | Treatment after induction, lasts 24 h | 0.050, 0.100 and 0.200 | ↑SOD | Lipid-loaded HepG2 cells | [ | ||
| Co-treatment, with induction, lasts 1.5 h | 1.000 | ↑SOD and GSH; ↓MDA | FeSO4 or CuSO4 and ascorbate induced 3T3 fibroblasts | [ |
CAT: Catalase; GPx: glutathione peroxidase; GSH: glutathione; MDA: malondialdehyde; SOD: superoxide dismutase; The arrows upward represent increase and the downward represent decrease.
Summary of recently reported molecular mechanisms of seaweed polysaccharides against oxidative stress.
| Seaweed | Compound | Source | Administration | Dose | Model | Possible Mechanism | Reference |
|---|---|---|---|---|---|---|---|
| Brown | Sulfated |
| Pretreatment 24 h before induction | 0.5 mg/L | Ethanol induced rat intestinal cell line IEC-6 | ↓JNK phosphorylation | [ |
| Fucoidan | Co-treatment with induction, lasts for 6 h | 0.5 mg/L | H2O2 induced pre- osteoblast-like | ↓caspase-3 and caspase-9 | [ | ||
| Co-treatment for 50 days | 400, 800 and 1600 mg/L | Heat Stress induced | ↑ | [ | |||
| After induction, treatment once daily, lasts for 14 days | 100 and 200 mg/Kg | Aβ induced Sprague–Dawley rats | ↑Bcl-2/Bax; ↓caspase-3 | [ | |||
| Sigma-Aldrich, USA | 24 h pretreatment | 0.1 and 1 μM | Aβ induced rat cholinergic basal forebrain neurons | ↓caspase-3 and caspase-9 | [ | ||
| 24 h treatment | 30 mg/L | human keratinocyte cell line (HaCaT) | ↑HO-1, SOD-1, Nrf2 and ERK; | [ | |||
| Pretreatment 1 h before induction | 20, 40, and 80 mg/kg | Lipopolysaccharide (LPS)-induced male BALB/c mice | ↑GSK-3β, Nrf2, and HO-1 | [ | |||
| Pretreatment 2 h before induction, lasts 2 days | 100 mg/kg | Acetaminophen induced Sprague–Dawley rats | ↑Bcl-2; ↓Bax and caspse-3 | [ | |||
| Alginate | Sigma Aldrich, USA | Pretreatment 1 h before induction | 30 mg/L | H2O2 induced NT2 neural | ↑HO-1, γ-GCS, Hsp-70 and Nrf2; | [ | |
| Laminarin | Sigma-Aldrich, USA | Treatment 1 h before or after induction, lasts 24 h | 20 mg/L | H2O2 induced Human lung fibroblasts MRC-5 cells | ↑Nrf2, NQO1, GCLC and HO1; ↓KEAP1 | [ | |
| Fucoidan | Cool Chemistry CO. | Pretreatment once daily, lasts 7 days | 100 and 200 mg/kg | APAP included human normal hepatocyte HL-7702 cell line | ↑Nrf2; ↓JNK Phosphorylation and ASK1 | [ | |
| Green | sulfated |
| Co-treatment, with induction, lasts 1.5 h | 1000 mg/L | FeSO4 or CuSO4 and ascorbate induced 3T3 fibroblasts | ↓caspase-3 and caspase-9 | [ |
ASK1: apoptosis signal-regulating kinase 1; Bax: Bcl-2 associated X protein; Bcl-2: B-cell lymphoma 2; ERK: extracellular regulated protein kinases; GSK-3β: Glycogen synthase kinase3β; HO-1: hemeoxygenase-1; JNK: jun N-terminal kinase; Keap1: Kelch ECH associating protein 1; Nrf2: nuclear factor erythroid 2-related factor 2; γ-GCS: Glutamylcysteine synthetase; The arrows upward represent increase and the downward represent decrease.
Figure 1Schematic representation of Nrf2 signaling pathway regulated by seaweed polysaccharides.
Figure 2Schematic representation of apoptotic pathway regulated by seaweed polysaccharides.